— On track to achieve third consecutive year of revenue growth –
— Second consecutive quarter of favorable net product sales to sales and marketing expense ratio —
Read more at prnewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
— On track to achieve third consecutive year of revenue growth –
— Second consecutive quarter of favorable net product sales to sales and marketing expense ratio —
Read more at prnewswire.comSymbol | Last | Chg | %Chg |
---|---|---|---|
EVFM | 0.0091 | -0.0002 | -2.15% |
Evofem Biosciences Inc |